Drug-Coated versus Plain Balloon Angioplasty in Bypass Vein Grafts (the DRECOREST I-Study)

Editor's Choice – Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

“…Studies comparing endovascular techniques are scarce. 49 In the case of multiple restenosis, surgical revision and replacement of the diseased segment with a vein interposition or a jump graft/patch angioplasty in the anastomotic stenosis is recommended. In the case of Figure 4.…”

A case of occluded femoropopliteal saphenous vein bypass with threatening limb ischemia treated with endovascular stent graft relining

“…However, the patency is suboptimal less than 30% after one year of follow-up, and unfortunately, SVG FP bypass restenosis or reocclusion has been encountered in daily clinical practice at a substantial frequency. 4 This patient's leg and life were saved by stent-graft deployment under a unique endo-conduit J o u r n a l P r e -p r o o f strategy. The pave and crack technique was first described for endoconduit in iliac arteries with causing controlled rupture to facilitate the safe introduction of aortic stent-grafts through diseased access vessels.…”

“…3 However, some studies reported that the clinical results following DCB use did not differ from conventional therapy. 4 Best alternative therapy for refractory SVG restenosis remains controversial. Herein, we report a previously unreported alternative therapy in which a stent-graft was used for re-occluded SVG FP bypass.…”

Effect of drug-coated balloons in treatment of stenosis of the femoral artery and vein bypass graft not responding to plain old balloon angioplasty: a case report

“…DCB with anti-proliferation agents, such as paclitaxel or everolimus, was approved for femoropopliteal lesions in Japan in 2017 according to evidence from some randomized trials that demonstrated the superiority of DCBs over POBA in treatment [9][10][11][12][13][14][15][16]. However, the effect of DCBs on vein bypass grafts is controversial; Bjorkman et al showed a trend in favor of DCBs in bypass grafts [5], but other reports did not demonstrate the superiority of DCBs over POBA [6][7][8]. As there are various causes of graft failure, these studies might lack the patient cohort volume to reveal a drug effect on IH.…”

“…The drug-coated balloon (DCB) has recently emerged and is expected to be a powerful tool in replacing POBA as it can achieve excellent outcomes, including increased limb salvage rate or amputation-free rate in the treatment of femoropopliteal lesions, which has recently been reported. However, there are only a few reports suggesting that DCB is beneficial for bypasses using autogenous grafts [5][6][7][8]. Among the various methods of improving the patency, the effect of antiproliferative drugs on intimal hyperplasia (IH) of the anastomotic site is particularly attractive.…”